Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 09, 2018 08:00 ET | Source: Vasomune Therapeutics

Vasomune Therapeutics Appoints Douglas A. Hamilton as President and Chief Executive Officer

Toronto, ON, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Vasomune Therapeutics, a leading biotechnology company developing therapeutics targeting vascular dysfunction and inflammation, announced today Douglas...